Table 2. Underlying pulmonary conditions and their effect on 106 chronic pulmonary aspergillosis.
Underlying pulmonary diseases | Patients | Kaplan-Meier analysis | |||||
---|---|---|---|---|---|---|---|
1-year survival (%) | 3-year survival (%) | P value (log-rank test) |
|||||
With | Without | With | Without | ||||
COPD | 23 (21.7) | 73±9.5 | 92.7±2.9 | – | 84.5±4.4 | 0.21 | |
Lung tuberculosis | 7 (7.1) | 85.7±13.2 | 90.8±2.9 | – | 86.2±3.6 | 0.94 | |
Emphysema | 37 (34.9) | 75.2±7.2 | 92.6±3.2 | 64.9±9.3 | 85.9±4.8 | 0.02 | |
NTM | 6 (5.7) | 83.3±15.2 | 91±2.9 | – | 86.4±3.5 | 0.89 | |
Bronchiectasis | 75 (70.8) | 91.9±3.2 | 76.2±7.9 | 86.6±4.2 | 33.4±24.1 | 0.052 | |
Lung cancer | 8 (7.5) | 14.6±13.5 | 90.8±2.9 | – | 88.3±3.3 | <0.001 | |
Lung tuberculosis scarring | 25 (23.6) | 77.9±8.8 | 91.3±3.1 | 62.3±15.6 | 83.6±4.4 | 0.28 |
Data are presented as mean ± standard deviation or n (%). COPD, chronic obstructive pulmonary disease; NTM, non-tuberculous mycobacterium.